Cytodyn Inc (CYDY)

[Saltz]

“My biggest gripe is that Nader hasn’t found a way to reward SH and giving them a path to cash out”

Greed can kill science no matter how strong it is. We have a incompetent miscalculating CEO that is well on his way to dismantling this investment. Worst case used to be $3-$5 per share, not anymore. As BL say he as always thought the company could sell the science for $500M - 1B in a day. Unfortunately we may find out if that is true in the next six months.

This is why Nader has to be replaced. His pathway is unreasonable for where we are currently in the development of Leronlimab. If we continue down this road the SP and Balance Sheet will back this investment further into a corner with diminishing leverage.

Most think BK is impossible. Well consider what that means - we get whatever the company can be auctioned off for when we are unable to hold off our creditors. You can only stretch this so far. The fact that we are in this position is inexcusable.

I know OHM will say we can always raise funds at .20 and then .10. Yes but how much and how many takers will there be with Nader’s inability to ever deliver. That will be the beginning of the end because it may not be enough and it will dilute this investment to oblivion. I know it doesn’t matter because the molecule is worth a minimum of $10-$20B. Does that strategy make one feel secure and confident. It just compounds the already high risk to ridiculous odds.

How long will it takes for SH’s and the BOD to come to their senses?